The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by O'loughlin Steve since 2017.
The trader's CIK number is 1615840.
At the time of the last reporting, O'loughlin Steve was the Principal Financial Officer of Actinium Pharmaceuticals, Inc.. (stock ticker symbol ATNM).
Also see all insider trading activities at Actinium Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ATNM | 22,000 | $10,350 | 0 | $0 | 0 | $0 |
| 2017 | ATNM | 3,500 | $4,094 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-10 | ATNM | Buy | 10,000 | .43 | 4,350 |
| 2018-06-15 | ATNM | Buy | 12,000 | .50 | 6,000 |
| 2017-06-15 | ATNM | Buy | 3,500 | 1.17 | 4,094 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'loughlin Steve (Principal Financial Officer of Actinium Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.